Posters and White Papers

White Papers

API Sparing Techniques for Inhalation Toxicology Studies
R. Narayanan and P. Ahrweiler

Inhalation toxicology studies often require large quantities of drug substance. However, available API may be limited by expensive or difficult manufacturing. Learn how to conserve API in early preclinical studies with these API-sparing inhalation dosing techniques.

Posters

Development of Venezuelan Equine Encephalitis Bioaerosol Models In Mice and Marmosets For Use In Therapeutic Evaluation
2017 ASM Biothreats, Washington, DC

Influenza A Exposure Exacerbates Pneumonic Plague Infection in Swiss Webster Mice
Options IX for the Control of Influenza 2016, Chicago, IL

Development of an Aerosol Delivery System for Multiple Simultaneous Exposures of Rabbits to Aerosolized Bacillus anthracis
ASM Biodefense and Emerging Diseases 2016, Arlington, VA

Development of a Murine Bacillus anthracis Treatment Model Using a 21 day Ciprofloxacin and Doxycycline Dosing Schedule
ASM Biodefense and Emerging Diseases 2015, Washington, DC

Antiviral Activity of Enisamium Against Influenza Viruses in Differentiated Normal Human Bronchial Epithelial Cells
3rd Antivirals Congress 2014, Amsterdam, The Netherlands

Comparative Pharmacokinetics of the Polyphenol, Pterostilbene, in Rhesus Macaques, Cynomolgus Macaques, and Common Marmosets
Society of Toxicology 53rd Annual Meeting 2014, Phoenix, AZ

Repeat Dose Rabbit Vaginal Tolerance/ Toxicity Study of Diindolylmethane Cream for Topical Treatment of Cervical Intraepithelial Neoplasia
Society of Toxicology 53rd Annual Meeting 2014, Phoenix, AZ

Development of Francisella tularensis Schu S4 Post-exposure Prophylaxis and Delayed Treatment Models
ASM Biodefense and Emerging Diseases 2014, Washington, DC

Development of Yersinia pestis CO92 Aerosol Post-exposure Prophylaxis and Delayed Treatment Models
ASM Biodefense and Emerging Diseases 2014, Washington, DC

An Automated Microneutralization Plaque Assay to Measure Serum Antibodies against Influenza A Virus H1, H5 and H7 Subtypes
Infectious Diseases World Summit 2013, Boston, MA